INTRODUCTION
In a récent lecture, the plant breeder Norman Borlaug (1970 Nobel Peace Prize Lauréate) underlined that plant biotechnology is likely to be instrumental in dealing with the complexities of "feeding a world of 10 billion people" (1) that the current population of 5.8 billion would certainly reach during the next century before stabilizing. Agricultural biotechnology is expected to play a particular rôle in the less developed countries (LDCs) where still 800 million underfed people are concentrated but where spécial constraints and challenges are faced with. For example, the population in the Third World relies to a large extent on staple crops as cassava, sweet potato and tropical fruits that are hardly known in the developed countries. As a resuit, highquality scientific research is scarce with thèse crops. In addition, the tropical climate that prevails in most LDCs causes a number of significant conséquenc-es, e.g. due to the absence of dormancy, (i) many tropical crops propagate (exclusively) vegetatively which makes classical breeding extremely difficult, and (ii) pathogens and pests can permanently damage their hosts.
BANANA: A CASE STORY
Banana is a very characteristic case to describe the dimensions and problems biotechnological research will meet in the Third World. With more than 85 million metric tons annually produced mainly in backyards and small farms in 120 countries (2), banana is the No. 1 fruit crop in the world which is not only consumed fresh or as dessert but baked, boiled, cooked, fried and even brewed to béer or puréed for baby food. Ninety percent of banana production is consumed locally and serves as staple food for some 400 million people Worldwide due to the high starch content. In fact, banana is the fourth major food source (after rice, milk and wheat) in the developing world. In addition, the export value of the 10% production entering international trade is estimated to US $3 billion that générâtes a significant income for the economy of numerous LDCs. AH thèse facts and figures demonstrate that banana isactually the most important fruit crop on earth.
On the other hand, most cultivated bananas are parthenocarpic landraces that are stérile triploids. This and their relatively long life cycle hinders successful hybridization programstotransfer disease résistance from wild diploid sources. In addition, many landraces become susceptible to several viral, bacterial and fungal pathogens as well as the nematode and insect pests that cause steadily increasing problems in commercial plantations, too. For instance, the annual cost of fungicide sprays against the pathogen of black Sigatoka leaf disease, Mycosphaerella fijiensis, ranges between US$600 and 1800 per hectare which amounts up to 40% of the total production cost. Such sprayings are carried out almost every week and pose a high pressure to the environment as documented by the fré-quent reported fish-kills in the neighborhood of banana plantations. Highly toxic nematicides are also heavily used, some of which sterilized 13,000 plantation workers in Costa Rica in the early 1980s. Finally, smallholders and individuals who cannot afford or hâve access to chemicals hâve to cope with yield déclines of 30% or more.
While significant basic scientific knowledge is missing in many fields of banana research, important progress has been made recently in other areas (reviewed in réf. 3). For instance, no classical genetic maps are available, cytology and classical cytogenetics has been hardly done, and plant-pathogen interactions hâve been very poorly characterized as well. On the other hand, banana is one of the most extensively micropropagated species in the world and various advanced in vitro culture techniques hâve been adapted for the production of regenerable embryogén-ie cell suspension and protoplast cultures. Based on this progress, foreign gènes were introduced into banana protoplasts and the first transgenic plants were produced either by particle bombardment of embryogénie cell suspension cultures or by Agrobacteriummediated transformation of cultured meristems. While, due their sterility, most banana cultivars do not produce seeds under natural conditions and crosses with other cultivars or species will not occur, hère this handicap turns out to be an apparent advantage because the introduced transgene(s) remain(s) confined to the cultivar in which it has been introduced. Based on this argument banana can be considered as a low risk species for transgenic field trials as also confirmed by a theoretical model from différent viewpoints (4).
FUNGAL DISEASE CONTROL BY GENETIC TRANSFORMATION
Since the most significant damage as well as future threat to banana production are caused by fungal pathogens, the introduction of gènes conferring résistance to thèse pathogens is a primary research target. Our efforts are presently focused on several gènes encoding stable, cysteine-rich antimicrobial peptides (AMPs) which are isolated from seeds of diverse plant species (reviewed in réf. 5). Thèse AMPs hâve a broad anti-fungal spectrum and show high in vitro activity against field isolâtes of Mycosphaerella fijiensis and Fusarium oxysporum, the two main fungal pathogens of banana, while they exert notoxicityto human or plant cells. To date, five AMP gènes hâve been introduced in our laboratory alone and in double-or triple combinations into embryogénie cell suspension cultures of banana using particle bombardment. Large-scale molecular and biochemical characterization of the regenerated transgenic lines confirmed that a vast majority contained and expressed the foreign gènes. For example, extensive PCR-screening of a total of 776 putative transgenic plants revealed that more than 90% of them contained the selectable marker gène as well as the AMP gènes. Similarly, Southern hybridization of 56 independent transgenic plants demonstrated that 89.3% had the transgenes integrated in their génome.
Tostudy the expression of antimicrobial peptides in the transgenic plants, some of the AMP gènes was placed under the control of three différent promoters which had previously been shown to drive high gène expression in banana as well as in other monocots. Using spécifie antibodies, the concentration of two AMPs in total transgenic leaf protein extracts ranged from 0.05% to more than 1% depending on the promoter used. Addition of thèse leaf extracts to germinating spores and mycelia of a field isolate of Mycosphaerella fijiensis, the causal agent of black Sigatoka leaf disease, resulted in a significant inhibition of fungal growth making thèse plants likely candidates to control this pathogen under field conditions. In addition, screening of 50 independent transgenic lines with a new in situ leaf bioassay allowed us to sélect and micropropagate lines with improved résistance to several fungal pathogens.
Field tests will demonstrate whether thèse transgenic plants express the functional AMPs at levels high enough to control fungal leaf or root diseases in nature. It has been shown that one foreign AMP gène is also transcribed in the fruit, opening the opportunity to create résistance against pre-and postharvest diseases such as cigar-end rot and crown rot.
INTRODUCTION OF TRANSGENIC PLANTS TO THIRD WORLD COUNTRIES: CONCERNS AND IMPACTS
Once transgenic plants hâve been produced, their further management and field release requires the careful coordination of a large number of factors. For instance, field release must be authorized by national governments through their respective regulatory bodies. According to our expérience, field testing in thèse countries should definitely involve an active breeding program (such as a CGIAR institute) to ensure that plants are evaluated correctly and précise observations are taken. However, in many LDCs operational regulatory bodies are not yet in place, and this causes delays in implementing field testing of transgenic plants. Additional delaying factors in many LDCs and especially in sub-Saharan Africa are: political instability, récent économie recession, lack of trained personnel (scientists, lawyers) devoted to clear confusion and suspicion and decrease bureaucracy.
To date, no transgenic banana plants are being tested in the field. This is essentially due to the lack of functional regulatory bodies as well as to the underlying reasons in the countries where testing would be carried out. In view of the fact that more and more transgenic plants are being produced by laboratories Worldwide, the lack of regulatory mechanisms is likely to continue to be a major bottleneck to progress. It is therefore recommended that greater efforts, at both national and international level, be made to résolve this situation.
Finally, in view of the limited resources being devoted to tropical crop research, it is important that donor agencies put emphasis on supporting collaboration between successful breeding institutions and advanced biotechnology laboratories. However, for correct perception of the real situation, it may be interesting to know that the total plant biotechnology-related investment of CGIAR currently amounts to about US$15 million which is lessthan what a small biotechnology company spends on R&D in the United States (6). On the other hand, black Sigatoka résis-tant bananas alone would produce at least US$6 billion added value if cultivated in sub-Saharan Africa only.
QUESTIONS
What could be the optimal size of a transgenic field test for résistance to a single pathogen: e.g. number of transgenic and control lines, number of individuals per line, etc?
How can efficient mechanisms be activated (esp. in the Third World) to change suspicion with transgenic plants and to accelerate légal procédures for the authorisation of field tests? Which stratégies can be adapted for using publicly acceptable target gènes and avoiding selectable marker gènes in vegetatively propagating plants?
